Patent · US Active

Substituted pyrimidine compounds

US9540349B2 · kind B2 · utility

2Cited by
1References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 15, 2015
Grant dateJan 10, 2017
Priority date
Expiry dateJul 15, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to novel substituted pyrimidine compounds of general formula (I)in which the chemical groupings, substituents, variables and indices are as defined in the description, and to their use as medicaments, in particular as medicaments for the treatment of conditions and diseases that can be treated by inhibition of the PDE4 enzyme.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.